Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
International Journal of Dermatology|June 8, 2020
Clinical and histological characteristics, and management of melanoma in French Guiana, 2007-2018Marine Broly, Kinan Drak Alsibai, Beatrice Cenciu, et al.Bulletin Du Cancer|July 8, 2025
Management of metastatic uveal melanoma: French expert consensus guidelinesManuel Rodrigues, Vincent Servois, Pascale Mariani, et al.Oncotarget|April 28, 2016
Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patientsJérôme Fayette, Clara Fontaine-Delaruelle, Alexis Ambrun, et al.Oncotarget|September 9, 2017
Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03Jerome Fayette, Joel Guigay, Christophe Le Tourneau, et al.Journal of Neuro-Oncology|April 10, 2021
Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screeningValentine Ruste, Marie Pierre Sunyach, Ronan Tanguy, et al.Immunotherapy|August 4, 2018
Primary malignant melanoma of the esophagus, treated with immunotherapy: a case reportPauline Rochefort, Juliette Roussel, Arnaud de la Fouchardière, et al.Cancer Immunology, Immunotherapy : CII|February 28, 2008
Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinomaJaafar Bennouna, Emmanuelle Bompas, Eve Marie Neidhardt, et al.Lung Cancer (Amsterdam, Netherlands)|March 31, 2023
Occupational asbestos exposure and survival among lung cancer patientsHugo Noelle, Olivia Pérol, Maurice Pérol, et al.European Journal of Cancer (Oxford, England : 1990)|September 28, 2022
An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastasesCaroline Dutriaux, Caroline Robert, Jean-Jacques Grob, et al.Head & Neck|October 13, 2021
Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocolElise Rowinski, Nicolas Magné, Jérôme Fayette, et al.Pageof 3